Transplantation of Patients with Hepatocellular Carcinoma Through Increased Utilization of Machine Perfusion Technology

Transplantation of Patients with Hepatocellular Carcinoma Through Increased Utilization of Machine Perfusion Technology

Background. With the intent to mitigate waitlist disparities, the median model for end-stage liver disease (MELD) at transplant minus 3 policy nevertheless decreased access to liver transplant for patients with hepatocellular carcinoma (HCC). However, the adoption of machine perfusion (MP) technolog...

Full description

Saved in:
Bibliographic Details
Main Authors: Lauren E. Matevish, MD, Jason Guo, BS, Andrew D. Shubin, MD, PhD, Malcolm MacConmara, MD, Christine S. Hwang, MD, Nathanael Raschzok, MD, Nicole E. Rich, MD, MSCS, Arjmand R. Mufti, MD, Amit G. Singal, MD, MS, Parsia A. Vagefi, MD, Madhukar S. Patel, MD, MBA, ScM
Format: Article
Language:English
Published: Wolters Kluwer 2025-04-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001777
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items